Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

39.05 -1.56 (-3.84%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 11, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,265,020
Open	40.27
Bid (Size)	38.00 (100)
Ask (Size)	39.10 (100)
Prev. Close	40.61
Today's Range	38.91 - 40.39
52wk Range	32.63 - 90.32
Shares Outstanding	8,168,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

March 11, 2026

From SkyMedia, LLC

Via GlobeNewswire

Law Offices of Howard G. Smith Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action

March 11, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Performance

YTD	-17.2%	-17.2%
1 Month	-4.5%	-4.5%
3 Month	-21.9%	-21.9%
6 Month	-34.9%	-34.9%
1 Year	-12.8%	-12.8%

More News

Law Offices of Frank R. Cruz Encourages Soleno Therapeutics, Inc. (SLNO) Shareholders To Inquire About Securities Fraud Class Action

March 11, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox

March 11, 2026

Via NewMediaWire

Deadline to Lead in Securities Fraud Lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) is May 5, 2026 - Contact Kaplan Fox

March 11, 2026

Via TheNewswire.com

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

March 10, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

March 10, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

SOLENO THERAPEUTICS, INC. (SLNO) INVESTOR ALERT Investors With Large Losses in Soleno Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

March 10, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 10, 2026

From Schall Law

Via GlobeNewswire

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

March 10, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026

March 10, 2026

Via NewMediaWire

Kaplan Fox Alerts Investors to a Securities Class Action Against Soleno Therapeutics, Inc. (SLNO) - Deadline is May 5, 2026

March 10, 2026

Via TheNewswire.com

Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SLNO

March 10, 2026

From DJS Law Group

Via Business Wire

Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

March 09, 2026

From Law Offices of Howard G. Smith

Via Business Wire

Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

March 09, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026

March 09, 2026

Via NewMediaWire

Kaplan Fox Encourages Investors of Soleno Therapeutics, Inc. (SLNO) to Contact the Firm Before Lead Plaintiff Deadline on May 5, 2026

March 09, 2026

Via TheNewswire.com

Securities Fraud Investigation Into Soleno Therapeutics, Inc. (SLNO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

March 09, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

SOLENO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. and Encourages Investors to Contact the Firm

March 09, 2026

From Bragar Eagel & Squire

Via GlobeNewswire

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 09, 2026

From The Schall Law Firm

Via Business Wire

SLNO DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

March 09, 2026

From Faruqi & Faruqi LLP

Via GlobeNewswire

Rosen Law Firm Urges Soleno Therapeutics, Inc. (NASDAQ: SLNO) Stockholders to Contact the Firm for Information About Their Rights

March 09, 2026

From Rosen Law Firm

Via Business Wire

INVESTOR NOTICE: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit filed by Robbins Geller Rudman & Dowd LLP

March 09, 2026

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit

March 06, 2026

From Robbins LLP

Via Business Wire

Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts ↗

February 27, 2026

Via Stocktwits

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?

Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?

Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?

The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market

What is the current price of Soleno Therapeutics, Inc. - Common Stock?

The current price of Soleno Therapeutics, Inc. - Common Stock is 39.05

When was Soleno Therapeutics, Inc. - Common Stock last traded?

The last trade of Soleno Therapeutics, Inc. - Common Stock was at 03/11/26 04:00 PM ET

What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?

The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 318.99M

How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?

Soleno Therapeutics, Inc. - Common Stock has 319M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.